Tools

The bacterium B. cereus had so far been considered to be exclusively endospore-forming. In response to harsh conditions, the bacteria… »   

Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats… »   

The U.S. food and Drug Administration said it was strengthening an existing warning label that non-aspirin, non-steroidal anti-inflammatory drugs (NSAIDs)… »   

Researchers from the Johns Hopkins Bloomberg School of Public Health have located a new - and likely more promising, they… »   

According to a new study, women experiencing difficulty with time management, attention, organization, memory, and problem solving - often referred… »   

An existing anti-stroke drug is an effective treatment for middle-ear infections, showing the ability to suppress mucus overproduction, improve bacterial… »   

The drug dasabuvir (trade name Exviera) has been available since January 2015 for the treatment of adults with chronic hepatitis… »   

The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma… »   

A new study finds that effective new hepatitis C drugs are so expensive the state of Rhode Island would have… »   

Well intentioned, but costly and potentially problematic. That’s how researchers describe the end result of a decision by the Food… »